Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60 yr of age

Abstract

Recipients over 60 yr receiving rATG induction have acceptable renal function and a low risk of rejection; however, reduced survival was noted among those receiving >6 mg/kg. These data suggest that when used, lower cumulative dosages of rATG are preferable in the older recipient.